The UK Competition Authority investigates on a pharma company for abuse of dominance (Essential Pharma)

On 6 October 2020, the Competition and Markets Authority ( CMA ) started an inquiry into Essential Pharma to determine whether that company abused an allegedly dominant position when announcing the withdrawal from the UK market of Priadel®,

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Authors

Quotation

Peter L'Ecluse, Catherine Longeval, Koen T'Syen, The UK Competition Authority investigates on a pharma company for abuse of dominance (Essential Pharma), 6 October 2020, e-Competitions November 2020 - II, Art. N° 97096

Visites 151

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues